Candel Therapeutics (NASDAQ:CADL) Director Paul Manning Purchases 550,458 Shares
Candel Therapeutics, Inc. (NASDAQ:CADL - Get Free Report) Director Paul Manning bought 550,458 shares of the firm's stock in a transaction dated Monday, February 23rd. The stock was bought at an...